PANAMA CITY, Jan. 9, 2026 /PRNewswire/ — Transitioning from late 2025 into early 2026, the crypto market saw a recovery in risk appetite despite ongoing volatility. As market liquidity gradually improved, capital rotated from defensive positions toward high-beta, sentiment-driven sectors, thrusting memecoins back into the spotlight.

Over the past week (December 29, 2025 – January 4, 2026), multiple newly listed assets on HTX recorded impressive gains. Memecoins across BSC, Solana, Base, Ethereum, and TRON ecosystems rallied, marking one of the most representative market trends of the week.

Memecoin Sector: Multi-Chain Rallies Driven by Accelerating Momentum

This week’s top gainers were dominated by memecoin projects, reflecting a sustained capital preference for assets with high consensus and strong virality.

On BNB Smart Chain (BSC), BROCCOLI (CZ’s dog) stood out as the top performer, surging 170% over the week. As an active memecoin project within the BSC ecosystem, BROCCOLI rapidly attracted capital through community-driven dissemination and sentiment resonance. Meanwhile, 4 (FOUR) gained 48%, PALU rose 37%, and Binance Life increased 19%, highlighting a broad-based pickup in the BSC memecoin sector.

The Solana ecosystem maintained its strength. PONKE (Ponke) climbed 104% this week, supported by rising community engagement and expanding trading volume, making it a flagship asset within the SOL memecoin space. BONK (Bonk) advanced 44%, while BOME (Book of Meme) gained 37%, signaling continued development potential for Solana-based memecoins.

Other ecosystems also posted notable gains. On Ethereum, leading memecoin PEPE rose 64%. On TRON, memecoin SUNDOG (Sundog) increased 39% over the week. Within the Base ecosystem, BRETT (Brett) recorded a 43% weekly gain. These moves underscore that both the royal public chains and the emerging Layer2 networks continue to attract capital under the memecoin narrative.

AI Sector: Selective Recovery Led by the Base Ecosystem

While memecoins drove short-term retail sentiment, the AI sector experienced a “structural recovery,” with strength concentrated primarily within the Base ecosystem.

GAMEBASE (Game by Virtuals) surged 60% during the week. As an AI agent gaming framework supported by Virtuals, GAME attracted attention at the intersection of AI, blockchain gaming, and application-layer narratives. Meanwhile, VIRTUAL (Virtuals Protocol) rose 40%, driven by its positioning as an AI and Metaverse protocol focused on virtual interaction. Overall, AI assets exhibited a structural recovery rather than a sentiment-driven surge. While short-term momentum lagged memecoins, AI assets continue to hold mid-term allocation value within broader narrative cycles.

*Disclaimer: The above content is provided for market information and trend analysis purposes only and does not constitute any investment advice. Digital asset prices are highly volatile. Investors are advised to trade rationally and manage risks accordingly.

HTX Listing Strategy: Multi-Sector Coverage with a Value-Oriented Focus

The market performance this week followed a clear “sentiment-first, memecoin-led” pattern. With strong consensus, rapid dissemination, and high volatility, memecoins became the primary short-term destination for capital. At the same time, assets from the narrative-driven sectors such as AI showed selective recovery across specific chains, offering diversified opportunities.

Through high-frequency listing and multi-chain asset deployment, HTX continues to expand listing coverage across core narratives including memecoin and AI, providing users with a broader range of trading opportunities. In 2026, HTX’s asset listing strategy will maintain high sensitivity to market trends while reinforcing a value-focusing philosophy through progressively stricter listing standards. By combining forward-looking deployment in high-growth assets with refined selection, HTX aims to amplify the wealth effect of quality assets and help users capture more deterministic opportunities in the fast-growing crypto market.

About HTX

Founded in 2013, HTX (formerly Huobi) has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit https://www.htx.com/ or HTX Square , and follow HTX on X, Telegram, and Discord. 

LAS VEGAS, Jan. 9, 2026 /PRNewswire/ — The article is reported by Shuzhi Society

At a launch event held today at CES 2026, Dreame Robot Laundry, a global leader in high-end consumer electronics and intelligent manufacturing, officially introduced its flagship laundry solution, the AI Dual Inverter Washer & Dryer Set L9 and the Embodied AI Laundry Care Robot, to the North American market. The newly launched product L9 has been honored with the “Best of CES 2026” award by leading tech media outlets TECHAERIS and Techlicious, showcasing a significant leap in intelligent, hands-free fabric care powered by proprietary AI and world-leading systems.

AI embodied laundry care robot: The future family’s laundry companion

Dreame’s first AI embodied laundry care robot integrates cutting-edge “embodied intelligence technology” with household laundry care scenarios, leading the evolution from “automation” to “autonomy” in laundry. Equipped with a self-developed AI multimodal sensing system, the robot uses visual, tactile, and other sensors to accurately identify your intentions and stain levels for intelligent sorting. Its outstanding feature is a high-precision bionic robotic arm, which employs advanced control algorithms to mimic the gentle grasping and adaptive movement of human hands, enabling delicate and precise handling of various fabrics.

In real-world home applications, the robot independently performs the entire laundry cycle—from sorting and collecting clothes to washing and drying. It can sense its surroundings, plan optimal routes, and continuously learn user habits to offer personalized laundry solutions.

Fully Integrated Design: A Fusion of Function and Aesthetics

The L9 Set features a Fully Integrated Design, serving not only as a high-performance appliance but also as an enhancement to home aesthetics. Its sleek, fully fit-in body is tailored for standard 700mm cabinets, allowing it to blend seamlessly into modern living spaces.

The four core advantages make L9 stand out

The L9’s AI Full-Wash Control intelligently identifies the load and dynamically optimizes cleaning for efficiency with less residue. Advanced hygiene care is achieved through high-temp sterilization & mite removal cycle with drum auto-clean. The dual-inverter heat pump dryer offers thorough, fast, and efficient drying. Additionally, the PressFree function smooths a shirt in 25 minutes, while FreshLoop Plasma Fresh Air Circulation prevents odors and reduces wrinkles for up to 12 hours for the forgotten laundry.

Product Availability and Price

The Dreame AI Dual Inverter Washer & Dryer Set L9 will be launched on the Dreame official website and AliExpress in March 2026.

SANYA, China, Jan. 9, 2026 /PRNewswire/ — The Hainan (Sanya) Marathon, held over the last weekend of 2025, marked the inaugural Class A-certified event sanctioned by the China Athletics Association (CAA) since the commencement of operations in the Hainan Free Trade Port (Hainan FTP) under its independent customs and trade regulations. Hainan FTP’s advantages in easier visa access, air connectivity, duty-free trade, and international mobility were reflected in strong participation and on-the-ground activity. The marathon boosted local tourism, dining, and accommodation, with hotel occupancy reaching 92% and commercial spending along the course rising by about 35%.

Yang Yong, General Manager of Events and Commercialization at event partner Orange Lion Sports (formerly Alibaba Sports), said organizers drew on resources across the Alibaba ecosystem – including Taobao, Fliggy, Alibaba Health, Ant Chain, and Amap – to broaden the event’s reach and connect more effectively with domestic and international running audiences, encouraging greater participation in event-related spending.

Hainan FTP offers visa-free entry to citizens of 86 countries, and its international air network links 25 destinations across Asia and Europe, further improving accessibility for international participants. Under the new customs and trade framework, the list of items eligible for duty-free import expanded from 1,900 to over 6,600, allowing previously duty-bound race equipment and supplies to be brought in tax-free, which helped significantly reduce event costs.

According to the organizers, the expanded list lowered procurement expenses for timing systems, professional supplies, and audio equipment. The resulting savings were reinvested in operations, runner services, and marketing, enhancing overall quality and reach, while also strengthening commercial appeal and attracting more sponsors and partners.

The marathon’s impact extended beyond race weekend. Fliggy data show hotel bookings rising steadily since late October, with partner hotels maintaining this upward trend during the event. Coinciding with the first New Year and Spring Festival holiday under the new customs arrangements, the event further stimulated consumer spending. According to the Sanya Bureau of Tourism, Culture, Radio, Television and Sports, the city welcomed 650,800 visitors during the 2026 New Year holiday, generating RMB 1.299 billion in tourism spending. The combined momentum of the event and holiday travel contributed to a notable increase in overall market activity.

The success of the Hainan (Sanya) Marathon demonstrates how major sporting events now bridge tourism, hospitality, and international spending.

GUANGZHOU, China, Jan. 9, 2026 /PRNewswire/ — From March 18 to 31, 2026, the 57th China International Furniture Fair (CIFF Guangzhou 2026) will be held in Guangzhou under the theme CONNECT•CREATE. The Home Furniture Exhibition, as one of the three key exhibitions of CIFF Guangzhou, will take place from March 18 to 21. Spanning 430,000 square meters, it will allow overseas brands, buyers, and designers to engage with China’s supply chain, track global trends, and explore emerging business opportunities.

The upcoming edition will expand its scope with more brands in commercial design, upholstered, dining&living, outdoor furniture, and home décor, reflecting structural shifts in the global furniture market.

CONNECT Global Design, Lifestyle, and Future Trend

Design continues to shape the industry’s future, and CIFF 2026’s East Design Show will span 40,000 square meters, featuring 100+ brands driving soft furnishings innovation.

In response to global demand, the fair will spotlight solutions shaped by evolving lifestyles and demographic shifts. In Area D, curated showcases will highlight age-friendly furniture and smart eldercare solutions from around 150 companies in the Silver Life section, while the Pet Life section will explore design influenced by the growing trend of human–pet co-living.

Complementing this, a 10,000-square-meter smart living area will present solutions such as intelligent sleep systems and health monitoring technologies, aligning with growing demand for healthier home environments.

Outdoor living will remain a key focus, with a 50,000-square-meter zone highlighting innovation across the outdoor ecosystem and nature-inspired lifestyles. The home décor segment will emphasize sustainability and cultural heritage, responding to rising interest in environmentally responsible design.

CREATE New Possibilities, Growth, and International Reach

The dining and living room furniture sector will further reinforce the fair’s positioning as “Made for the World.” Covering 120,000 square meters and uniting 800+ manufacturers, the showcase will highlight supply chain efficiency and design-driven manufacturing. High-end products will demonstrate how advanced production capabilities translate into competitive designs, while dedicated platforms will enable more direct connections between manufacturers and international consumers.

SOFA PLUS will return with more brands, improved navigation, and enhanced services for global audiences, positioning itself as a key gateway for Chinese sofa brands worldwide.

As one of the world’s largest furniture exhibitions, CIFF Guangzhou serves as a key bridge between China and the global furniture industry, delivering tangible value in trade matchmaking and trend insight. Visit https://www.ciff-gz.com/en for more information.

CASTRES, France and PARIS, Jan. 9, 2026 /PRNewswire/ — Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. This initiative reflects both companies’ commitment to advancing oncology research by integrating complementary strengths across computational design, medicinal chemistry, biology, medical science and preclinical development.

Under the terms of the agreement, Iktos will leverage its AI-driven generative design platform to accelerate the discovery of optimized small-molecule candidates against an undisclosed oncology target. Pierre Fabre Laboratories will contribute its extensive knowledge in oncology research and preclinical development to guide the selection, evaluation, and progression of candidate molecules.

Financial terms of the agreement are not disclosed but include an upfront and several milestone payments.

“This collaboration with Iktos marks an important milestone in our journey to build an AI-powered R&D engine at Pierre Fabre Laboratories” said Audrey Kauffmann, Head of Data Science and Biometry at Pierre Fabre Medical Care R&D. “By integrating Iktos’ generative AI and automated chemistry technologies into our research platforms, we are taking a step toward realizing our data and AI strategy. This cooperation exemplifies our ambition to leverage cutting-edge innovation to improve the quality and probability of success in drug discovery, while accelerating the delivery of meaningful advances for patients in oncology.”

“We are delighted to start a drug discovery collaboration with Iktos”, said Olivier Geneste, Head of Drug Discovery at Pierre Fabre Medical Care R&D. “Thanks to its well-established expertise in generative AI coupled to automated chemistry, we strongly believe that Iktos will help us in accelerating and derisking the discovery of innovative therapeutics targeting a highly valuable oncology target to serve unmet cancer patients’ needs.”

“We are delighted to initiate this collaboration with Pierre Fabre Laboratories, a company with a distinguished track record in oncology,” said Yann Gaston-Mathé, Co-founder and CEO of Iktos. “This collaboration exemplifies the powerful complementarity between Iktos’ generative AI and automated chemistry technologies and Pierre Fabre’s deep scientific and clinical development expertise. Together, we intend to create the optimal framework to rapidly and efficiently progress innovative small-molecule candidates in oncology, with the aim of bringing meaningful therapeutic advances to patients worldwide.”

About the Pierre Fabre Laboratories R&D pipeline:

Pierre Fabre Laboratories has expanded its efforts in precision oncology by adding several assets to its R&D pipeline. PFL-241 and PFL-721, two mutant-selective EGFR inhibitors, are being developed for the treatment of EGFR-driven non-small cell lung cancer (NSCLC) patients. PFL-002 is undergoing clinical testing in solid tumors driven by MET genetic alterations. The pan-RAF inhibitor exarafenib is being developed to expand targeted therapy options for RAS/RAF-driven solid tumors. Moreover, pre-clinical candidates for various oncology targets are sought to be identified in collaboration with Vernalis Ltd. Furthermore, a collaboration with RedRidge Bio is underway to identify and develop biparatopic antibodies for multiple targets in precision oncology, dermatology, and rare diseases. These new additions to the discovery and clinical development portfolio complement Pierre Fabre Laboratories’ existing precision oncology portfolio targeting BRAF, MEK, HER2, as well as EBV-driven post-transplant lymphoproliferative disorder.

About Pierre Fabre Laboratories

Pierre Fabre Laboratories is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio includes international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow and Elgydium. Its Medical Care activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases, primary care and family health care.   

For over 40 years, Pierre Fabre Laboratories has established itself as an international player in oncology, mastering the entire value chain from R&D to marketing. Its portfolio of oncology specialties covers colorectal, breast, lung and skin cancers, as well as certain hematologic malignancies and precancerous dermatological conditions such as actinic keratosis. In 2024, Pierre Fabre Laboratories’ revenues in oncology came to 520 million euros, 88% of which were generated by international sales, out of a total sales figure of 3.1 billion euros.

Based in southwest France since its creation, Pierre Fabre Laboratories manufactures nearly 90% of its products in France and employs 10,200 people worldwide. In 2024, its R&D budget amounted to 219 million euros, of which 60% is allocated to targeted therapies in oncology and 35% to skin health and care solutions. There are currently 10 research and development programs underway dedicated to targeted therapies in oncology.

Pierre Fabre Laboratories’ majority shareholder (86%) is an eponymous humanitarian Foundation. Employees constitute the company’s other shareholder. This capital structure guarantees the company’s independence, long-term vision and contribution to the common good. The dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.

Pierre Fabre Laboratories’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development).

For more information, visit www.pierre-fabre.com, @Laboratoires Pierre Fabre, @Pierre Fabre Oncology

About Iktos

Founded in 2016, Iktos is a global leader in artificial intelligence and robotics for drug discovery. Its generative AI technology designs molecules in silico, optimized to meet all key success criteria of a discovery project. Through software and strategic collaborations with pharmaceutical companies, Iktos combines AI-driven molecular design with robotic synthesis and biological testing, to accelerate drug discovery. With over 60 successful projects to date, Iktos is also advancing its own pipeline of drug candidates in oncology, obesity and metabolism, inflammatory and autoimmune diseases. The company completed a €15.5M Series A financing round in 2023, co-led by M Ventures and Debiopharm Innovation, with participation from Omnes Capital. In 2024, Iktos acquired Synsight, strengthening its platform with cutting-edge cellular imaging and high-content biological screening capabilities. In 2025, Iktos was awarded a €2.5M grant from the European Innovation Council (EIC) Accelerator, with potential follow-on funding of €5M, to advance its integrated AI and robotics platform. For more information, visit Iktos.ai.

Media Contacts

Pierre Fabre Laboratories

Yasmine Benyahia
yasmine.benyahia@pierre-fabre.com 

LAS VEGAS, Jan. 9, 2026 /PRNewswire/ — As the premier global tech event kicking off the new year, CES (Consumer Electronics Show) opened grandly in Las Vegas, bringing together innovative products from thousands of technology companies worldwide. It serves as a key platform for unveiling the latest advancements in future technologies. Making its debut at CES, InfiMotion Technology, a Chinese supplier providing electric drive products, presented its breakthrough EDUs, demonstrating its global innovation capabilities in high-voltage architecture, lightweight materials, and system integration. This marks a significant step in how Chinese smart manufacturing is empowering the global high-end electric vehicle supply chain.

The three products showcased by InfiMotion represent major leaps in material innovation, system integration, high-voltage platform, and efficiency—all designed to empower the next generation of intelligent electric vehicles with exceptional performance and energy economy.

High-Performance Magnesium-Aluminum Alloy Dual-Motor System
Featuring an innovative ultra-lightweight magnesium-aluminum alloy housing, this product delivers 340kW of peak power while weighing only 109.5 kg, achieving a power density of 3.1 kW/kg. Already in mass production and deployed in models such as the Galaxy M9 and Lynk & Co 900, it incorporates torque vectoring control to enable a “waltz-style tank turn.”

900V High-Performance Coaxial Dual E-Drive with Magnesium Alloy Housing
Using a coaxial planetary configuration, this product achieves 92.4% CLTC efficiency at operating voltages above 750V, with a power density breakthrough of 5.69 kW/kg. With magnesium alloy, its weight reduces by 30%. InfiMotion’s proprietary deep oil-cooling technology for both stator and rotor enhances thermal performance, enabling over 80 consecutive full-throttle accelerations without performance degradation.

Ultra-Integrated 12-in-1 Domain Control E-Drive
By integrating 12 core modules including the motor, reducer, MCU, VCU, BMS, DC-DC, etc., this 400V IGBT-based EDU achieves 90% CLTC efficiency with a total weight under 79.8 kg. This solution is already in use in the Geely Galaxy E5.

As a global technology partner rooted in China, InfiMotion has established an end-to-end system from R&D to mass production delivery, and is collaborating closely with mainstream and luxury automotive brands worldwide to shape the future of electric mobility.

About InfiMotion Technology
InfiMotion Technology is positioned as a full-stack electric drive component and system solution provider, with comprehensive R&D and manufacturing capabilities spanning from components to top-level systems. Its headquarters is located in Wuxi, China, with five intelligent manufacturing bases and six R&D centers worldwide.